JJC HdhNfWo
UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Category: Science and Tech

More Americans Could Benefit from Paxlovid for COVID Infection

Johns Hopkins One of the best tools for preventing severe complications from COVID infection is the prescription antiviral drug Paxlovid. But not nearly as many people who could benefit from it are being prescribed it, says Amesh Adalja, MD, FIDSA, a senior scholar at the Johns Hopkins Center for Health Security who specializes in infectious diseases and pandemic […]

Feb 6, 2024

Why Aren’t More Doctors Prescribing Paxlovid to High-Risk Patients?

MedPage Today It’s not all about drug-drug interactions, experts say. Recent evidence is piling up that many people at high risk for severe COVID-19 don’t receive nirmatrelvir/ritonavir (Paxlovid) — or any outpatient antiviral treatment — when diagnosed with a SARS-CoV-2 infection. MedPage Today looked at new studies and talked to experts to find out why. In a […]

Jan 30, 2024

Why does COVID-19 make you sneeze?

Science Viral protein stimulates nerves in respiratory passages, could be target for treatment SARS-CoV-2 has many ways of making people miserable, including by causing them to sneeze. Now, researchers have discovered the basis for this nose-tickling effect. One of the virus’ proteins stimulates neurons in respiratory passages, triggering the sneeze reflex. The results could spawn […]

Jan 23, 2024

Paxlovid helps prevent severe illness from COVID. Why don’t more people take it?

Yahoo News With the current COVID-19 death toll in the U.S. at more than 1.1 million and new evidence that COVID infections can damage the brain, heart and lungs, it’s clear that the disease is more than “just a bad cold.” Paxlovid, which is a combination of two drugs (nirmatrelvir and ritonavir), can lower the risk of severe symptoms […]

Jan 23, 2024

Why Don’t Covid Tests Seem to Work as Well as They Used To?

Bloomberg With Covid outbreaks being whipped up for a fifth year, testing has emerged as a source of frustration once again. Whereas obtaining a test was often difficult in early 2020, now the abundance of cheaper rapid kits in grocery stores and home medicine cabinets has led to a new concern — they don’t seem […]

Jan 16, 2024

Should I take Paxlovid if I get covid? Here’s what to know.

Washington Post Paxlovid lowers risk of serious illness and hospitalization, and may help prevent long covid, yet many patients don’t use the drug. The antiviral drug Paxlovid can significantly reduce symptoms of covid-19 and dramatically lower the risk of severe illness or dying of the disease. Yet many eligible people aren’t using it, and some […]

Jan 16, 2024

A big shift in collecting COVID data — from case counts to monitoring poop

NPR Earlier this year, the CDC stopped collecting data on new infections (as in positive tests) – relying instead on COVID hospitalizations, deaths and, increasingly, on wastewater surveillance – a network set up during the pandemic to regularly test sewage samples from around the country. The surveillance network has expanded beyond COVID to track flu, RSV, norovirus and other health threats that are […]

Dec 26, 2023

Scientists Identify Interferon-gamma as Potential SARS-CoV-2 Antiviral

NIH Conditioning the lungs with interferon-gamma, a natural immune system protein (cytokine) best known for fighting bacterial infections, appears to be a strong antiviral for SARS-CoV-2, according to National Institutes of Health scientists and colleagues. Their new study, published in Nature Communications, shows in two different mouse models that when a bacterial infection triggers the release […]

Dec 12, 2023

New blood testing method advances disease detection

Arizona State University Researchers at the Arizona State University Biodesign Institute have made an impressive leap in disease detection, with a novel screening method that can look at hundreds of disease markers and evaluate thousands of samples simultaneously, delivering most results in 24 hours. Unlike conventional blood tests, the new platform, called Multiplexed In-Solution Protein […]

Dec 12, 2023

Pre-Existing SARS-CoV-2 T Cells Predicted to Recognize New Pirola Variant

Genetic Engineering and Biotechnology News SARS-CoV-2 variants continue to evolve (even if they are no longer making headlines.)  In August, researchers detected a new SARS-CoV-2 “variant of concern” in patients, first in Israel and Denmark. Over the past few months, this variant, BA.2.86 or “Pirola,” has made its way around the globe. The Pirola variant […]

Dec 12, 2023